Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ivermectin Treatment Efficacy in Covid-19 High Risk Patients (I-TECH Study): A Multicenter Open-label Randomized Controlled Trial

NCT04920942 is registered in ClinicalTrials.gov with Clinical Research Centre, Malaysia as lead sponsor.

NCT NCT04920942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04920942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ivermectin Treatment Efficacy in Covid-19 High Risk Patients (I-TECH Study): A Multicenter Open-label Randomized Controlled Trial
Lead sponsor
Clinical Research Centre, Malaysia
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2021
Completion date
October 31, 2021
Enrollment
500 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19